Skin fold thickness at abdomen: A simple anthropometric measurement may compliment metabolic syndrome definition in patients with normal waist circumference

Journal of Geriatric Cardiology

Volumn 3, Issue 2, 2006, Pages 85-92

  Nguyen, Toan C ^a,b   Ngo, Thai Q ^a   Nguyen, Son V ^a   Luong, Hieu T ^a   Pham, Khoa T A ^a   Nguyen, Cong D ^a  

^a VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^b Undergraduate Unit of Military Medical University   (Viet Nam)

Author keywords

Hypertension; Metabolic syndrome; Skin fold thickness

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC SYNDROME X; OBESITY; SEX DIFFERENCE; SKINFOLD THICKNESS; WAIST CIRCUMFERENCE;

EID: 33748942980     PISSN: 16715411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation Technical Report Series 894, Geneva, Swizerland 2000.
2. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/MetS_def_FINAL.pdf.
3. Robert HE, Scott MG, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-28.
4. Defrono RA, Ferrannini E. Insulin Resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerosis cardiovascular disease. Diabetes Care 1991;14:173-94
5. Kaplan NM. Systemic Hypertension: Mechanism and Diagnosis. Definitions, Prevalence and Consequences of Hypertension. 6th. New York, NY: Heart Disease 2001: 941-57.
6. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinemia and coronary heart disease. Diabetologia 1994;37:948-952.
7. World Health Organization, Western Pacific Region. The Asia-Pacific Perspective. Redefining Obesity and its Treatment. WHO/IASO/IOTF 2000.
8. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus, Geneva, World Health Organization 1999; (publ.no.WHO/NCD/NCS/99.2).
9. Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005;365:1398-1405.
10. Hu G, Qiao Q, Tuomilehto J, et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Inter Med 2004;164: 1066-76.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
12. Hunt KJ, Resendez RG, Williams K, et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004;110:1251-7.
13. Faloia E, Giacchetti G, Mantero F. Obesity and Hypertension. J Endocrinol Invest 2000;23:54-62.
14. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005;81:555-63.
15. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351-75.
16. Chan NN, Kong AP, Chan J CN. Metabolic Syndrome and Type 2 Diabetes: The Hong Kong Perspective. Clin Biochem Rev 2005;26: 51-7.
17. Shirai K. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin 2004;20:295-304.
18. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The Metabolically obese, normal weight individual revisited. Diabetes 1998;47: 699-713.
19. Lee S, Janssen I, Ross R. Interindividual variation in abdominal subcutaneous and visceral adipose tissue: influence of measurement site. J Appl Physiol 2004;97:948-54.
20. Goodpaster BH, Thaete FL, Simoneau JA and Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997; 46:1579-85.
21. Ross R, Shaw KD, Martel Y, et al. Adipose tissue distribution measured by magnetic resonnance imaging in obese women. Am J Clin Nutr 1993;57:470-5.
22. Abate N, Garg A, Peshock R, et al. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes 1996;45:1684-93.
23. Abate N, Garg A, Peshock RM, et al. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96:88-98.
24. Nguyen TC, Pham K TA, Nguyen T, et al. Relationship between skin fold thickness and insulin resistance in the essential hypertensive patients in Vietnam. J Geriatr Cardiol 2005;2(4):228-32.
25. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004;27:1182-6.
26. Thomas Phillip, Rafael Schaefers. Metabolic syndrome and arterial hypertension. 1st. Germany. Druckhaus Köthen GmbH: The metabolic syndrome 1997: 69-75.
27. Haffner SM. Syndrome X: Insulin resistance hyperinsulinemia the key?. The metabolic syndrome. 1st. Germany. Druckhaus Köthen GmbH: The metabolic syndrome 1997:25-37.
28. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality and middle-aged men. JAMA 2002; 288:2709-16.
29. Sorrentino, MJ. Obesity, hypertension and the metabolic syndrome. J Geriatr Cardiol 2006;3(1):59-60.
30. Huang KC, Lee MS, Lee SD, et al. Obesity in the elderly and its relationship with cardiovascular risk factors in Taiwan. Obes Res 2005; 13:170-8.
31. Hanson RL, Imperatore G, Betnett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002;51:3120-7.
32. Diabetes Prevention Program Research Group. Hypertension, insulin and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40:679-93.
33. Laaksonen DE, Kainulainen S, Rissanen, Niskanen L. Relationships between changes in abdominal fat distribution and insulin sensitivity during a very low calorie diet in abdominally obese men and women. Nutr Metab Cardiovasc Dis 2003;13:349-56.
34. Van Itallie TB. Health implications of overweight and obesity in the United States. Ann Intern Med 1985;103:983-8.
35. Waganknecht LE, Langefeld CD, Haffner SM, et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003;52:2490-6.
36. Chan DC, Watts GF, Barrett PHR and Burke T. Wasist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 2003;96:441-7.
37. Lundgren H, Bengtsson C, Blohme G, et al. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden, Int J Obesity 1989;13:413-23.
38. Spangler JG, Bell RA, Summerson JH, Konen JC. Hyperinsulinemia in hypertension: associations with race, abdominal obesity, and hyperlipiddemia. Arch Fam Med 1998;7(1):53-6.
39. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atheroclerosis, gout, and uric calculons disease. Am J Clin Nutr 1956;4:20-34.
40. Tai ES, Lau TN, Ho SC, et al. Body fat distribution and cardiovascular risk in normal weight women. Associations with insulin resistance, lipids and plasma leptin. Intern J Obes 2000;24:751-7.
41. Lewis GF, Uffelman KD, Szeto LW, et al. Interaction between free fatty acids and insulin in the acute control of very low density liporprotein production in humans. J Clin Invest 1995;95:158-66.
42. Eckel RH, Yost TJ, Jensen DR. Alterations in lipoprotein lipase in insulin resistance. Int J Obes Relat Metab Disord 1995;19(1):S16-S21.
43. Guo Z, Hensrud DD, Johnson CM, Jensen DM. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 1999;48:1586-92.
44. Wang J, Deurenberg P. The validity of predicted body composition in Chinese adults from anthropometry and bioelectrical impedance in comparison with densitometry. Br J Nutr 1996;76:175-82.
45. Janssen I, Heymsfield SB, Allison DB, et al. Body mass index and waist circumference independently contribute to the prediction of nonabdominal subcutaneous and visceral fat. Am J Clin Nutr 2002;75:683-8.
46. Bonona E, Ghiatas M, Lancaster JL, et al. Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism 1995;44:1617-25.
47. Sung RY, Tong PC, Yu CW, et al. High prevalence of insulin resistance in the metabolic syndrome in overweight/obese pre-adolescent Hong Kong Chinese children aged 9-12 years. Diabetes Care 2003;26:250-1.
48. Mossberg HO. Fourty year follow up of overweight children. Lancet 1989;2:491-3.
49. Steinberger J, Moorehead C, Katch V, Rocchini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995;126:690-5.
50. Jiang X, Srinivasan SR, Bao W, Berenson GS. Association of fasting insulin with blood pressure in young individuals. Arch Intern Med 1993;153:323-8.
51. Freedman DS, Dietz WH, Srinavasan SR, Berenson GS. Relation of overweight to cardiovascular risk factors among children and adolescents. The Bogulusa Heart Study. J Pediatr 1999;103:1175-82.